Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.
Matt MG, Drozdov D, Bendstrup E, Glerup M, Hauge EM, Masmas T, Schneider EC, Zeilhofer UB, Abu-Arja RF, Driest KD, Oved JH, Onel K, Ebens CL, Chellapandian D, Chandrakasan S, Prahalad S, Roth J, Prockop SE, Silva J, Schapiro AH, Towe C, Chandra S, Grom A, Schulert GS, Marsh RA. Matt MG, et al. Among authors: oved jh. Lancet Rheumatol. 2024 Dec 20:S2665-9913(24)00275-3. doi: 10.1016/S2665-9913(24)00275-3. Online ahead of print. Lancet Rheumatol. 2024. PMID: 39718183
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E, Farooki S, Klein E, Mauguen A, Prockop SE, Scaradavou A, Curran K, Cancio M, Spitzer B, Boelens JJ, Oved J, Harris A, O'Reilly RJ, Kernan NA. Fraint E, et al. Transplant Cell Ther. 2023 Jan;29(1):46.e1-46.e6. doi: 10.1016/j.jtct.2022.09.027. Epub 2022 Oct 6. Transplant Cell Ther. 2023. PMID: 36210027 Free PMC article.
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.
Abraham RS, Basu A, Heimall JR, Dunn E, Yip A, Kapadia M, Kapoor N, Satter LF, Buckley R, O'Reilly R, Cuvelier GDE, Chandra S, Bednarski J, Chaudhury S, Moore TB, Haines H, Dávila Saldaña BJ, Chellapandian D, Rayes A, Chen K, Caywood E, Chandrakasan S, Lugt MTV, Ebens C, Teira P, Shereck E, Miller H, Aquino V, Eissa H, Yu LC, Gillio A, Madden L, Knutsen A, Shah AJ, DeSantes K, Barnum J, Broglie L, Joshi AY, Kleiner G, Dara J, Prockop S, Martinez C, Mousallem T, Oved J, Burroughs L, Marsh R, Torgerson TR, Leiding JW, Pai SY, Kohn DB, Pulsipher MA, Griffith LM, Notarangelo LD, Cowan MJ, Puck J, Dvorak CC, Haddad E. Abraham RS, et al. Clin Immunol. 2024 Apr;261:109942. doi: 10.1016/j.clim.2024.109942. Epub 2024 Feb 15. Clin Immunol. 2024. PMID: 38367737
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.
Oved JH, Russell A, DeZern A, Prockop SE, Bonfim C, Sharma A, Purtill D, Lakkaraja M, Bidgoli A, Bhoopalan SV, Soni S, Boelens JJ, Abraham A. Oved JH, et al. Cytotherapy. 2025 Jan;27(1):78-84. doi: 10.1016/j.jcyt.2024.09.001. Epub 2024 Sep 6. Cytotherapy. 2025. PMID: 39320295 Free article. Review.
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.
Garcia-Rosa M, Abraham A, Bertaina A, Bhoopalan SV, Bonfim C, Cohen S, DeZern A, Louis C, Oved J, Pavel-Dinu M, Purtill D, Ruggeri A, Russell A, Sharma A, Wynn R, Boelens JJ, Prockop S. Garcia-Rosa M, et al. Cytotherapy. 2023 Jun;25(6):578-589. doi: 10.1016/j.jcyt.2023.02.007. Epub 2023 Mar 21. Cytotherapy. 2023. PMID: 36941149 Review.
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee.
John TD, Maron G, Abraham A, Bertaina A, Bhoopalan SV, Bidgoli A, Bonfim C, Coleman Z, DeZern A, Li J, Louis C, Oved J, Pavel-Dinu M, Purtill D, Ruggeri A, Russell A, Wynn R, Boelens JJ, Prockop S, Sharma A. John TD, et al. Cytotherapy. 2024 Jul;26(7):660-671. doi: 10.1016/j.jcyt.2024.02.005. Epub 2024 Feb 20. Cytotherapy. 2024. PMID: 38483362 Free article. Review.
CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders.
Oved JH, Wang Y, Barrett DM, Levy EM, Huang Y, Monos DS, Grupp SA, Bunin NJ, Olson TS. Oved JH, et al. Biol Blood Marrow Transplant. 2019 Mar;25(3):549-555. doi: 10.1016/j.bbmt.2018.10.003. Epub 2018 Oct 9. Biol Blood Marrow Transplant. 2019. PMID: 30312755 Free PMC article.
Non-myeloablative conditioning is sufficient to achieve complete donor myeloid chimerism following matched sibling donor bone marrow transplant for myeloproliferative leukemia virus oncogene (MPL) mutation-driven congenital amegakaryocytic thrombocytopenia: Case report.
Oved JH, Shah YB, Venella K, Paessler ME, Olson TS. Oved JH, et al. Front Pediatr. 2022 Jul 28;10:903872. doi: 10.3389/fped.2022.903872. eCollection 2022. Front Pediatr. 2022. PMID: 35967582 Free PMC article.
36 results